nitroglycerin has been researched along with 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dröge, W; Lehmann, V; Ratter, F; Schirrmacher, V; Umansky, V; Ushmorov, A | 1 |
1 other study(ies) available for nitroglycerin and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
| Article | Year |
|---|---|
Nitric-oxide-induced apoptosis in human leukemic lines requires mitochondrial lipid degradation and cytochrome C release.
Topics: Apoptosis; Cardiolipins; Caspase 3; Caspase 9; Caspases; Chromans; Cytochrome c Group; Drug Resistance; Enzyme Activation; Genes, bcl-2; Humans; Jurkat Cells; Lipid Peroxidation; Lipolysis; Membrane Lipids; Mitochondria; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Oxidative Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Recombinant Fusion Proteins; Stimulation, Chemical; Transfection; Tumor Cells, Cultured | 1999 |